Ovid Technologies Field Guide

PDQ Cancer Information File (PDQC)


Scope

The Physician Data Query Cancer file contains prognostic and treatment information for over 80 different cancers. Included is up-to-date information on prognosis, staging, cellular classification and treatment options, both standard and under clinical investigation, along with references to medical literature. An editorial board of prominent oncologists meets each month to review and update the information in PDQC.

PDQC contains over 80 documents, each devoted to a particular cancer type. See Additional Notes for a list of the cancer names currently included in PDQC. For clinical trial information, search the PDQP database; for closed clinical trial information search the PDQB database.


General Information

Producer
National Cancer Institute
R.A. Bloch International Cancer Information Center
Building 82, Room 103
Bethesda, MD 20892
PDQ Service Desk:
301-496-7403
800-624-7890

Years of Coverage
Specific years are not applicable for this database. Current information is updated monthly to keep abreast of new developments

Default fields for unqualified searches
CN, SY, CT, PG, SS, SI, TO, TP

All Display/Print Fields
AN, UP, CN, SY, CT, SS, PG, SI, CC, TO, TP

Default Display/Print Fields
AN, CN, SS, PG, SI, CC, TP

Update Frequency
Monthly

Searching the PDQ Cancer Information File fields

The following alphabetical list provides the two-letter label, the relevant alias, and an example for each PDQ Cancer Information File database field.

=====        ============
Label        Name/Example
=====        ============
an           Accession Number [Word and Phrase Indexed]
example 1:   PDQC-000006.an.
example 2:   000006.an.

ca           Cancer Terminology Superlabel [CN, SY, CT fields]
example:     stomach cancer.ca.

cc           Cellular Classification [Word Indexed]
example:     ulcerating.cc.

cn           Cancer Name [Word Indexed]
example:     gastric cancer.cn.

ct           Cell Type/Stage [Word Indexed]
example:     recurrent gastric cancer.ct.

pg           Prognosis [Word Indexed]
example:     survival rate.pg.

si           Stage Information [Word Indexed]
example:     nodal involvement.si.

ss           Summary Statement [Word Indexed]
example:     advanced stage.ss.

sy           Synonyms [Word Indexed]
example:     stomach cancer.sy.

to           Treatment Overview [Word Indexed]
example:     combined modality.to.

tp           Treatment Options [Word Indexed]
example:     surgical resection.tp.

up           Update Code [Phrase Indexed]
example:     9703.up.

PDQ Cancer Information File Limit

Childhood Cancers
Sentence Syntax:   limit 1 to childhood cancers


Change to PDQ Cancer Information File from another database

Command Syntax:        ..c/pdqc
Sentence Syntax:       use pdqc

Sample PDQC Document

Accession Number
  PDQC-000006
Update Code
  9703
Cancer Name
  Gastric cancer
Synonyms
  Stomach cancer.
Cell Type
  Stage, gastric cancer.  Solid tumor.  Adult solid tumor.  Cellular
  diagnosis, gastric cancer.  Mixed adenocarcinoma of the stomach.
  Diffuse adenocarcinoma of the stomach.  Intestinal adenocarcinoma of
  the stomach.  Gastrointestinal cancer.  Adenocarcinoma of the
  stomach.  Body system/site cancer.  Stage 0 gastric cancer.
  Cancer.  Recurrent gastric cancer.  Stage IV gastric cancer. Stage
  III gastric cancer.  Stage II gastric cancer.  Stage I gastric
  cancer. Gastric cancer.
Prognosis
  (A separate statement containing information on screening for
  gastric cancer is also available in PDQ.)
  Cancer of the distal half of the stomach has been decreasing in the
  United States since the 1930s.  However, in the last 2 decades, the
  incidence of cancer of the cardia and gastroesophageal junction has
  been rapidly rising. The incidence of this cancer in patients
  especially under 40 years of age has increased dramatically.
  In localized distal gastric cancer, more than 50% of the patients
  are curable. However, early stage disease currently accounts for
  only 10%-20% of all cases diagnosed in the United States.  The
  remaining patients present with metastatic disease in either
  regional or distant sites.  The overall survival rate in these
  -sample truncated-
Stage Information
  Stages are defined by TNM classification.[1]
  -- TNM definitions --
  Primary tumor (T)
  Principal factor is degree of penetration of stomach wall by
  carcinoma
  TX:  Primary tumor cannot be assessed
  T0:  No evidence of primary tumor
  Tis: Carcinoma in situ:  intraepithelial tumor without invasion of
  the lamina propria
  T1:  Tumor invades lamina propria or submucosa
  T2:  Tumor invades the muscularis propria or the subserosa*
  T3:  Tumor penetrates the serosa (visceral peritoneum) without
  invading adjacent structures**
  T4:  Tumor invades adjacent structures**
*Note: A tumor may penetrate the muscularis propria with extension
 into the gastrocolic or gastrohepatic ligaments or into the greater
 or lesser omentum without perforation of the visceral peritoneum
 covering these structures.  In this case, the tumor is classified
 T2.  If there is gross or microscopic perforation of the visceral
 peritoneum covering the gastric ligaments or omenta, the tumor
 should be classified T3.
**Note: The adjacent structures of the stomach are the spleen,
 transverse colon, liver, diaphragm, pancreas, abdominal wall,
 adrenal gland, kidney, small intestine, and retroperitoneum.
 Intramural extension to the duodenum or esophagus is classified by the
 depth of greatest invasion in any of these sites, including
 stomach.
- sample truncated -
Cellular Classification
  The cellular classification relates only to adenocarcinomas and not
  to other cell types such as lymphoma and sarcomas.[1]
  Adenocarcinomas can be divided
  into the following subtypes:
    fungating or polypoid
    ulcerating
    superficial spreading
    diffusely spreading (linitis plastica)
Microscopically, four histologic types of adenocarcinoma may prove
to have prognostic significance:
    intestinal
    pylorocardial (or antral)
    signet ring cell [2]
-sample truncated-
Treatment Overview
  The designations in PDQ that treatments are "standard" or "under
  clinical evaluation" are not to be used as a basis for reimbursement
  determinations..
Treatment Options
  Stage 0 gastric cancer
  Stage 0 is gastric cancer confined to mucosa.  Experience in Japan
  where stage 0 is diagnosed frequently, indicates that greater than
  90% of patients treated by gastrectomy with lymphadenectomy will
  survive beyond 5 years.  An American series has confirmed these
  results.[1]
References:
    1. Green PH, O'Toole KM, Slonim D, et al.: Increasing incidence and
    excellent survival of patients with early gastric cancer: experience
    in a United States medical center.  American Journal of Medicine
    85(5): 658-661, 1988.
Stage I gastric cancer
Surgical resection including lymphadenectomy is the treatment of
choice for stage I gastric cancer.  If the lesion is not in the
cardioesophageal junction and does not diffusely involve the
stomach, subtotal gastrectomy is the procedure of choice since its
use is associated with improved survival over other procedures.
When the lesion involves the cardia, proximal subtotal gastrectomy
or total gastrectomy (including a sufficient length of esophagus)
may be performed with curative intent.  If the lesion diffusely
involves the stomach, total gastrectomy is required.  At a minimum,
surgical resection should include greater and lesser omentum and
regional lymph nodes.  Note that in patients with stage I gastric
cancer perigastric lymph nodes may contain cancer.
- sample document truncated-

PDQ Producer Copyright Information

Some material in the PDQ database is from copyrighted publications of the respective copyright claimants. Users of the database are referred to the publication data appearing in the bibliographic citations, as well as to the copyright notices appearing in the original publication, all of which are hereby incorporated by reference. The NCI represents that PDQ is formulated with a reasonable standard of care. Except for this representation, NCI makes no representations or warranties, express or implied, including any implied warranty of merchantability or fitness for a particular purpose, with respect to PDQ. The documents contained in PDQ may be retained for personal or educational use only. Information should not be edited or modified. Any resale or redistribution of all or portions of the information is not permitted.

Because use of the PDQ database for insurance reimbursement decisions is contrary to the nature of the database, which is designed as a research tool and not to reflect all possible treatment options, customers agree to not make the database available to users who wish to use it for reimbursement decision purposes.

Revised 7 July, 1998